Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel
  2. Monks, Anne; Zhao, Yingdong; Hose,Curtis; Hamed, Hossein; Krushkal, Julia; Fang, Jianwen; Sonkin, Dmitriy; Palmisano, Alida; Polley, Eric C.; Fogli, Laura K.; Konate, Mariam M.; Miller, Sarah B.; Simpson,Mel; Voth,Andrea; Li, Ming-Chung; Harris,Erik; Wu,Xiaolin; Connelly,John; Rapisarda,Annamaria; Teicher,Beverly; Simon, Richard; Doroshow, James H.
  3. Cancer research. 2018, Dec 15; 78(24): 6807-6817.
  1. 2.   Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit
  2. Wang, Guanqiao; Zhang, Mingzhen; Jang, Hyunbum; Lu, Shaoyong; Lin, Shizhou; Chen, Guoqiang; Nussinov, Ruth; Zhang, Jian; Gaponenko, Vadim
  3. Biochemistry. 2018, Mar 27; 57(12): 1917-1928.
  1. 3.   Rare germline variants in known melanoma susceptibility genes in familial melanoma
  2. Goldstein, Alisa M.; Xiao, Yanzi; Sampson, Joshua; Zhu, Bin; Rotunno, Melissa; Bennett, Hunter; Wen, Yixuan; Jones, Kristine; Vogt, Aurelie; Burdette, Laurie; Luo, Wen; Zhu, Bin; Yeager, Meredith; Hicks, Belynda; Han, Jiali; De Vivo, Immaculata; Koutros, Stella; Andreotti, Gabriella; Beane-Freeman, Laura; Purdue, Mark; Freedman, Neal D.; Chanock, Stephen J.; Tucker, Margaret A.; Yang, Xiaohong R.
  3. Human Molecular Genetics. 2017, Dec 15; 26(24): 4886-4895.
  1. 4.   A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
  2. Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum
  3. TRENDS IN PHARMACOLOGICAL SCIENCES. 2017, May; 38(5): 427-437.
  1. 5.   Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis
  2. Henrich, C. J.; Thomas, C. L.; Brooks, A. D.; Booth, N. L.; Lowery, E. M.; Pompei, R. J.; McMahon, J. B.; Sayers, T. J.
  3. Apoptosis. 2012, Jan; 17(1): 79-89.
  1. 6.   Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells
  2. Yao, X. H.; Liu, Y.; Chen, K. Q.; Gong, W. H.; Liu, M. Y.; Bian, X. W.; Wang, J. M.
  3. International Immunopharmacology. 2011, Dec; 11(12): 1961-1966.
  1. 7.   DNA repair: the culprit for tumor-initiating cell survival?
  2. Mathews, L. A.; Cabarcas, S. M.; Farrar, W. L.
  3. Cancer and Metastasis Reviews. 2011, Jun; 30(2): 185-197.
  1. 8.   Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
  2. Purdue, M. P.; Johansson, M.; Zelenika, D.; Toro, J. R.; Scelo, G.; Moore, L. E.; Prokhortchouk, E.; Wu, X. F.; Kiemeney, L. A.; Gaborieau, V.; Jacobs, K. B.; Chow, W. H.; Zaridze, D.; Matveev, V.; Lubinski, J.; Trubicka, J.; Szeszenia-Dabrowska, N.; Lissowska, J.; Rudnai, P.; Fabianova, E.; Bucur, A.; Bencko, V.; Foretova, L.; Janout, V.; Boffetta, P.; Colt, J. S.; Davis, F. G.; Schwartz, K. L.; Banks, R. E.; Selby, P. J.; Harnden, P.; Berg, C. D.; Hsing, A. W.; Grubb, R. L.; Boeing, H.; Vineis, P.; Clavel-Chapelon, F.; Palli, D.; Tumino, R.; Krogh, V.; Panico, S.; Duell, E. J.; Quiros, J. R.; Sanchez, M. J.; Navarro, C.; Ardanaz, E.; Dorronsoro, M.; Khaw, K. T.; Allen, N. E.; Bueno-De-Mesquita, H. B.; Peeters, P. H. M.; Trichopoulos, D.; Linseisen, J.; Ljungberg, B.; Overvad, K.; Tjonnel, A.; Romieu, I.; Riboli, E.; Mukeria, A.; Shangina, O.; Stevens, V. L.; Thun, M. J.; Diver, W. R.; Gapstur, S. M.; Pharoah, P. D.; Easton, D. F.; Albanes, D.; Weinstein, S. J.; Virtamo, J.; Vatten, L.; Hveem, K.; Njolstad, I.; Tell, G. S.; Stoltenberg, C.; Kumar, R.; Koppova, K.; Cussenot, O.; Benhamou, S.; Oosterwijk, E.; Vermeulen, S. H.; Aben, K. K. H.; van der Marel, S. L.; Ye, Y. Q.; Wood, C. G.; Pu, X.; Mazur, A. M.; Boulygina, E. S.; Chekanov, N. N.; Foglio, M.; Lechner, D.; Gut, I.; Heath, S.; Blanche, H.; Hutchinson, A.; Thomas, G.; Wang, Z. M.; Yeager, M.; Fraumeni, J. F.; Skryabin, K. G.; McKay, J. D.; Rothman, N.; Chanock, S. J.; Lathrop, M.; Brennan, P.
  3. Nature Genetics. 2011, Jan; 43(1): 60-U83.
  1. 9.   Finding the tumor copycat: approximating a human cancer
  2. Van Dyke, T.
  3. Nature Medicine. 2010, Sep; 16(9): 976-977.
  1. 10.   Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology
  2. Zhang, R. X.; Zhang, F. B.; Wang, C. J.; Wang, S. X.; Shiao, Y. H.; Guo, Z. J.
  3. Journal of Experimental & Clinical Cancer Research. 2010, Sep; 29: 7.
  1. 11.   Epigenetic gene regulation in stem cells and correlation to cancer
  2. Mathews, L. A.; Crea, F.; Farrar, W. L.
  3. Differentiation. 2009, Jul; 78(1): 1-17.
  1. 12.   A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
  2. Feng, Y.; Xiao, X. D.; Zhu, Z. Y.; Streaker, E.; Ho, M.; Pastan, I.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2009, May; 8(5): 1113-1118.
  1. 13.   Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
  2. Klarmann, G. J.; Hurt, E. M.; Mathews, L. A.; Zhang, X. H.; Duhagon, M. A.; Mistree, T.; Thomas, S. B.; Farrar, W. L.
  3. Clinical & Experimental Metastasis. 2009 26(5): 433-446.
  1. 14.   Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
  2. Sei, S.; Mussio, J. K.; Yang, Q. E.; Nagashima, K.; Parchment, R. E.; Coffey, M. C.; Shoemaker, R. H.; Tomaszewski, J. E.
  3. Molecular Cancer. 2009 8 AR 47
  1. 15.   Examining the significance of fingerprint-based classifiers
  2. Luke, B. T.; Collins, J. R.
  3. Bmc Bioinformatics. 2008 9
  1. 16.   Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
  2. Shanker, A.; Brooks, A. D.; Tristan, C. A.; Wine, J. W.; Elliott, P. J.; Yagita, H.; Takeda, K.; Smyth, M. J.; Murphy, W. J.; Sayers, T. J.
  3. Journal of the National Cancer Institute. 2008 100(9): 649-662.
  1. 17.   Angiogenesis as an immunopharmacologic target in inflammation and cancer
  2. Bian, X. W.; Chen, J. H.; Jiang, X. F.; Bai, J. S.; Wang, Q. L.; Zhang, X.
  3. International Immunopharmacology. 2004, NOV; 4(12): 1537-1547.
  1. 18.   Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse (vol 4, pg 434, 2003)
  2. Hingorani, S. R.; Petricoin, E. F.; Maitra, A.; Rajapakse, V.; King, C.; Jacobetz, M. A.; Ross, S.; Conrads, T. P.; Veenstra, T. D.; Hitt, B. A.; Kawaguchi, Y.; Johann, D.; Liotta, L. A.; Crawford, H. C.; Putt, M. E.; Jacks, T.; Wright, C. V. E.; Hruban, R. H.; Lowy, A. M.; Tuveson, D. A.
  3. Cancer Cell. 2004 5(1): 103-103.
  1. 19.   Prospective risk of cancer in CDKN2A germline mutation carriers
  2. Goldstein, A. M.; Struewing, J. P.; Fraser, M. C.; Smith, M. W.; Tucker, M. A.
  3. Journal of Medical Genetics. 2004 41(6): 421-424.
  1. 20.   An investigation into the human serum "interactome"
  2. Zhou, M.; Lucas, D. A.; Chan, K. C.; Issaq, H. J.; Petricoin, E. F.; Liotta, L. A.; Veenstra, T. D.; Conrads, T. R.
  3. Electrophoresis. 2004 25(9): 1289-1298.
  1. 21.   Structure and characterization of hamster IL-12 p35 and p40
  2. Maruyama, K.; Takigawa, Y.; Akiyama, Y.; Hojo, T.; Nara-Ashizawa, N.; Cheng, J. Y.; Watanabe, M.; Yamaguchi, K.
  3. Molecular Immunology. 2003 40(6): 319-326.
  1. 22.   Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
  2. Hingorani, S. R.; Petricoin, E. F.; Maitra, A.; Rajapakse, V.; King, C.; Jacobetz, M. A.; Ross, S.; Conrads, T. P.; Veenstra, T. D.; Hitt, B. A.; Kawaguchi, Y.; Johann, D.; Liotta, L. A.; Crawford, H. C.; Putt, M. E.; Jacks, T.; Wright, C. V. E.; Hruban, R. H.; Lowy, A. M.; Tuveson, D. A.
  3. Cancer Cell. 2003 4(6): 437-450.
  1. 23.   The diverse role of chemokines in tumor progression: Prospects for intervention (Review)
  2. Schneider, G. P.; Salcedo, R.; Welniak, L. A.; Howard, O. M. Z.; Murphy, W. J.
  3. International Journal of Molecular Medicine. 2001 8(3): 235-244.
  1. 24.   Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations
  2. Goldstein, A. M.; Struewing, J. P.; Chidambaram, A.; Fraser, M. C.; Tucker, M. A.
  3. Journal of the National Cancer Institute. 2000 92(12): 1006-1010.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel